Trade DMIIU anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Drugs Made In America Acquisition II Corp. Unit (DMIIU) is trading at US$10.25, up 0.49% today as of Aug 28, 11:13 EDT. The company has a market capitalisation of US$649.73M. Over the past 52 weeks, DMIIU has traded between US$9.94 and US$10.80. On Syfe you can trade DMIIU with $0 commission and add it to your watchlist.
| Previous close | US$10.20 |
|---|---|
| Market cap | US$649.73M |
| 52-week range | US$9.94 – US$10.80 |
| Volume | 1.76K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Drugs Made In America Acquisition II Corp. Unit
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in New York, NY.
Year: 2025
Drugs Made In America Acquisition II Corp. Unit (DMIIU) stock is trading at US$10.25, +0.49% from the previous close of US$10.20.
The market cap for Drugs Made In America Acquisition II Corp. Unit (DMIIU) stock is approximately US$649.73M.
The 52-week high for Drugs Made In America Acquisition II Corp. Unit (DMIIU) stock is US$10.80.
The 52-week low for Drugs Made In America Acquisition II Corp. Unit (DMIIU) stock is US$9.94.
Drugs Made In America Acquisition II Corp. Unit (DMIIU) does not currently pay a dividend.
Stay on top of DMIIU
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
